Go Global for Innovative Venous and Aortic Research

 

The 2016 Associate Faculty Global Podium session “Fascinating Venous and Aortic Topics” will be a series of presentations from experts from around the world on topics such as inflammatory aortic aneurysms and outcomes after endovascular-only repair, and emergency reconstruction of an inferior vena cava.

“There are presently multiple options for the treatment of both venous and arterial diseases. Surgeons will benefit by learning from others’ clinical experiences and operative techniques. This will help them in providing optimal therapy for each of their patients,” session co-moderator Dr. John Blebea said.

“Surgeons, by nature, are curious and always interested in learning new techniques or surgical skills,” said Dr. Blebea, professor of vascular surgery at the University of Oklahoma and immediate past president of the American Venous Forum. Co-moderating the session are Dr. Alan M. Dietzek of the University of Vermont and president-elect of the Society for Clinical Vascular Surgery; and Dr. Nick Morrison of the Morrison Vein Institute and President of the International Union of Phlebology.

“Those in academic medical centers benefit from the cross-pollination that occurs as trainees rotate on and off their services. In private practice, however, there are fewer opportunities to operate with or observe very many different surgeons,” Dr. Blebea said. “This session, on the other hand, will provide participants the chance not only to learn of surgical procedures from other surgeons, but from colleagues from around the world. Presenters will be representing China, India, Australia, Spain, Kosovo, Serbia and the United States. The prevalence of certain diseases varies across the world as well as the available surgical equipment. We can thus all learn from each other in how to deal with various surgical pathologies and how to do so in very different environments,” he said.

“The value of the presentations will further be enhanced by the commentary and critique of the three moderators, who are each experienced clinicians and world-recognized experts,” Dr. Blebea added.

“As the title of the session implies, this 3-hour conference will provide a fascinating glimpse into both venous and aortic arterial topics,” Dr. Blebea said. “The treatment of venous disease is an area of increasing interest and concern, on multiple levels. When one considers that an estimated 25 million Americans are affected by venous disease, ranging from cosmetic spider veins to recalcitrant non-healing ulcers, it is understandable that greater attention is being given to its treatment,” he noted.

“In addition, during the past two decades, there have been dramatic changes in the therapeutic options available. On the arterial side, advances in endovascular techniques now provide patients with interventions that are associated with less morbidity and mortality,” said Dr. Blebea. “However, there is also a need to customize interventions based on both anatomic restrictions and patient needs. This session will provide physicians with clinical insights which can be used immediately in their own practice, in a broad range of circumstances,” he emphasized.

 

"I think it is important to show support for the more junior members of our specialty," added Dr. Dietzek.  "This is a wonderful opportunity for U.S. and international, early career vascular surgeons, residents, and fellows to present their research at what is arguably the foremost vascular conference in the world. Attending this session will heighten the experience of the presenter and will be a learning experience for the attendee – a win-win!" 

Open surgery “remains a good and valid option for the treatment of inflammatory aortic abdominal aneurysms [IAAA],” according to Dr. Africa Duque-Santos of the Ramon y Cajal Hospital in Madrid, Spain. Dr. Santos presents results from 34 adult patients with IAAA; 29 were treated with open surgery and 5 with endovascular aneurysm repair (EVAR). After a median follow-up of 46 months (ranging from 24-112 months) renal function was equally stable in both groups. No significant differences were noted in the need for blood transfusion or intensive care, or in 30-day and long-term mortality rates, Dr. Duque-Santos said. Preoperative hydronephrosis was significantly more common in the EVAR group (3 patients, 60%) than in the open group (4 patients, 14%), but improvement in hydronephrosis occurred in 3 of 4 patients in the open group and 2 of 3 patients in the EVAR group.

 

“All patients with hydronephrosis in the open group received preoperative ureteral stenting; whereas none of the patients with hydronephrosis in the EVAR group received ureteral stents,” Dr. Duque-Santos noted.

Although the study included few patients treated with EVAR, the promising results support the need for further studies to assess long-term effectiveness; meanwhile, “open surgery remains a good and valid option for the treatment of IAAA,” Dr. Duque-Santos said.

Dr. Jianing Yue of Zhongshan Hospital Fudan University in Shanghai, will report that preoperative shock was associated with higher mortality rates in patients with truly-ruptured noninfected abdominal aortic aneurysms treated with and EVAR-optional approach (EVAR when possible) compared to those treated with an EVAR-only approach. Dr. Yue will describe data from a 7-year study including 80 adults; 27 died prior to surgery, 26 patients seen between March 2009 and April 2014were treated with EVAR if possible, and 27 seen between May 2014 and July 2016 were treated only with EVAR. In addition, the EVAR-only group had significantly shorter hospital stays than the open group (14 days vs. 34 days).

“Considering the shorter hospital stay, our results support superiority and more widespread adoption of emergent EVAR for the treatment of ruptured AAA,” Dr. Yue said.

Control of bleeding is a factor when injuries occur during accidents or surgery; Dr. Elmi Ism Olluri of Prishtina University Hospital, Kosovo, shares a case report of a 33-year-old patient who suffered extreme hypovolemic shock after blunt trauma to the right flank. The patient had complete rupture of the right kidney and a 7-cm long rupture of the infrarenal vena cava. The surgeons chose to reconstruct the infrarenal vena cava with a polytetrafluoroethylene graft. The patient also had an emergency laparotomy after a CT scan showed of a large abdominal blood clot. The patient was discharged 12 days after surgery, and 4 years later showed radiological evidence of blood flow in the IVC with a functional prosthetic graft. Salvage of a patient with a ruptured vena cava is rare, Dr. Olluri noted, but this case suggests that emergency polytetrafluoroethylene graft repair might be successful.

"Attend, attend, attend!" said co-moderator Dr. Deitzek.  "The topics are great, the presenters are young and eager and we can help foster their early careers and at the same time hear and learn about some very interesting, unusual and fascinating topics.  Be there or be square!"

Session 11
“Fascinating Venous and Aortic Topics”
Friday 7:05-9:46 a.m.
Bryant Suite, 2^nd Floor

 

The 2016 Associate Faculty Global Podium session “Fascinating Venous and Aortic Topics” will be a series of presentations from experts from around the world on topics such as inflammatory aortic aneurysms and outcomes after endovascular-only repair, and emergency reconstruction of an inferior vena cava.

“There are presently multiple options for the treatment of both venous and arterial diseases. Surgeons will benefit by learning from others’ clinical experiences and operative techniques. This will help them in providing optimal therapy for each of their patients,” session co-moderator Dr. John Blebea said.

“Surgeons, by nature, are curious and always interested in learning new techniques or surgical skills,” said Dr. Blebea, professor of vascular surgery at the University of Oklahoma and immediate past president of the American Venous Forum. Co-moderating the session are Dr. Alan M. Dietzek of the University of Vermont and president-elect of the Society for Clinical Vascular Surgery; and Dr. Nick Morrison of the Morrison Vein Institute and President of the International Union of Phlebology.

“Those in academic medical centers benefit from the cross-pollination that occurs as trainees rotate on and off their services. In private practice, however, there are fewer opportunities to operate with or observe very many different surgeons,” Dr. Blebea said. “This session, on the other hand, will provide participants the chance not only to learn of surgical procedures from other surgeons, but from colleagues from around the world. Presenters will be representing China, India, Australia, Spain, Kosovo, Serbia and the United States. The prevalence of certain diseases varies across the world as well as the available surgical equipment. We can thus all learn from each other in how to deal with various surgical pathologies and how to do so in very different environments,” he said.

“The value of the presentations will further be enhanced by the commentary and critique of the three moderators, who are each experienced clinicians and world-recognized experts,” Dr. Blebea added.

“As the title of the session implies, this 3-hour conference will provide a fascinating glimpse into both venous and aortic arterial topics,” Dr. Blebea said. “The treatment of venous disease is an area of increasing interest and concern, on multiple levels. When one considers that an estimated 25 million Americans are affected by venous disease, ranging from cosmetic spider veins to recalcitrant non-healing ulcers, it is understandable that greater attention is being given to its treatment,” he noted.

“In addition, during the past two decades, there have been dramatic changes in the therapeutic options available. On the arterial side, advances in endovascular techniques now provide patients with interventions that are associated with less morbidity and mortality,” said Dr. Blebea. “However, there is also a need to customize interventions based on both anatomic restrictions and patient needs. This session will provide physicians with clinical insights which can be used immediately in their own practice, in a broad range of circumstances,” he emphasized.

 

"I think it is important to show support for the more junior members of our specialty," added Dr. Dietzek.  "This is a wonderful opportunity for U.S. and international, early career vascular surgeons, residents, and fellows to present their research at what is arguably the foremost vascular conference in the world. Attending this session will heighten the experience of the presenter and will be a learning experience for the attendee – a win-win!" 

Open surgery “remains a good and valid option for the treatment of inflammatory aortic abdominal aneurysms [IAAA],” according to Dr. Africa Duque-Santos of the Ramon y Cajal Hospital in Madrid, Spain. Dr. Santos presents results from 34 adult patients with IAAA; 29 were treated with open surgery and 5 with endovascular aneurysm repair (EVAR). After a median follow-up of 46 months (ranging from 24-112 months) renal function was equally stable in both groups. No significant differences were noted in the need for blood transfusion or intensive care, or in 30-day and long-term mortality rates, Dr. Duque-Santos said. Preoperative hydronephrosis was significantly more common in the EVAR group (3 patients, 60%) than in the open group (4 patients, 14%), but improvement in hydronephrosis occurred in 3 of 4 patients in the open group and 2 of 3 patients in the EVAR group.

 

“All patients with hydronephrosis in the open group received preoperative ureteral stenting; whereas none of the patients with hydronephrosis in the EVAR group received ureteral stents,” Dr. Duque-Santos noted.

Although the study included few patients treated with EVAR, the promising results support the need for further studies to assess long-term effectiveness; meanwhile, “open surgery remains a good and valid option for the treatment of IAAA,” Dr. Duque-Santos said.

Dr. Jianing Yue of Zhongshan Hospital Fudan University in Shanghai, will report that preoperative shock was associated with higher mortality rates in patients with truly-ruptured noninfected abdominal aortic aneurysms treated with and EVAR-optional approach (EVAR when possible) compared to those treated with an EVAR-only approach. Dr. Yue will describe data from a 7-year study including 80 adults; 27 died prior to surgery, 26 patients seen between March 2009 and April 2014were treated with EVAR if possible, and 27 seen between May 2014 and July 2016 were treated only with EVAR. In addition, the EVAR-only group had significantly shorter hospital stays than the open group (14 days vs. 34 days).

“Considering the shorter hospital stay, our results support superiority and more widespread adoption of emergent EVAR for the treatment of ruptured AAA,” Dr. Yue said.

Control of bleeding is a factor when injuries occur during accidents or surgery; Dr. Elmi Ism Olluri of Prishtina University Hospital, Kosovo, shares a case report of a 33-year-old patient who suffered extreme hypovolemic shock after blunt trauma to the right flank. The patient had complete rupture of the right kidney and a 7-cm long rupture of the infrarenal vena cava. The surgeons chose to reconstruct the infrarenal vena cava with a polytetrafluoroethylene graft. The patient also had an emergency laparotomy after a CT scan showed of a large abdominal blood clot. The patient was discharged 12 days after surgery, and 4 years later showed radiological evidence of blood flow in the IVC with a functional prosthetic graft. Salvage of a patient with a ruptured vena cava is rare, Dr. Olluri noted, but this case suggests that emergency polytetrafluoroethylene graft repair might be successful.

"Attend, attend, attend!" said co-moderator Dr. Deitzek.  "The topics are great, the presenters are young and eager and we can help foster their early careers and at the same time hear and learn about some very interesting, unusual and fascinating topics.  Be there or be square!"

Session 11
“Fascinating Venous and Aortic Topics”
Friday 7:05-9:46 a.m.
Bryant Suite, 2^nd Floor

 

The 2016 Associate Faculty Global Podium session “Fascinating Venous and Aortic Topics” will be a series of presentations from experts from around the world on topics such as inflammatory aortic aneurysms and outcomes after endovascular-only repair, and emergency reconstruction of an inferior vena cava.

“There are presently multiple options for the treatment of both venous and arterial diseases. Surgeons will benefit by learning from others’ clinical experiences and operative techniques. This will help them in providing optimal therapy for each of their patients,” session co-moderator Dr. John Blebea said.

“Surgeons, by nature, are curious and always interested in learning new techniques or surgical skills,” said Dr. Blebea, professor of vascular surgery at the University of Oklahoma and immediate past president of the American Venous Forum. Co-moderating the session are Dr. Alan M. Dietzek of the University of Vermont and president-elect of the Society for Clinical Vascular Surgery; and Dr. Nick Morrison of the Morrison Vein Institute and President of the International Union of Phlebology.

“Those in academic medical centers benefit from the cross-pollination that occurs as trainees rotate on and off their services. In private practice, however, there are fewer opportunities to operate with or observe very many different surgeons,” Dr. Blebea said. “This session, on the other hand, will provide participants the chance not only to learn of surgical procedures from other surgeons, but from colleagues from around the world. Presenters will be representing China, India, Australia, Spain, Kosovo, Serbia and the United States. The prevalence of certain diseases varies across the world as well as the available surgical equipment. We can thus all learn from each other in how to deal with various surgical pathologies and how to do so in very different environments,” he said.

“The value of the presentations will further be enhanced by the commentary and critique of the three moderators, who are each experienced clinicians and world-recognized experts,” Dr. Blebea added.

“As the title of the session implies, this 3-hour conference will provide a fascinating glimpse into both venous and aortic arterial topics,” Dr. Blebea said. “The treatment of venous disease is an area of increasing interest and concern, on multiple levels. When one considers that an estimated 25 million Americans are affected by venous disease, ranging from cosmetic spider veins to recalcitrant non-healing ulcers, it is understandable that greater attention is being given to its treatment,” he noted.

“In addition, during the past two decades, there have been dramatic changes in the therapeutic options available. On the arterial side, advances in endovascular techniques now provide patients with interventions that are associated with less morbidity and mortality,” said Dr. Blebea. “However, there is also a need to customize interventions based on both anatomic restrictions and patient needs. This session will provide physicians with clinical insights which can be used immediately in their own practice, in a broad range of circumstances,” he emphasized.

 

"I think it is important to show support for the more junior members of our specialty," added Dr. Dietzek.  "This is a wonderful opportunity for U.S. and international, early career vascular surgeons, residents, and fellows to present their research at what is arguably the foremost vascular conference in the world. Attending this session will heighten the experience of the presenter and will be a learning experience for the attendee – a win-win!" 

Open surgery “remains a good and valid option for the treatment of inflammatory aortic abdominal aneurysms [IAAA],” according to Dr. Africa Duque-Santos of the Ramon y Cajal Hospital in Madrid, Spain. Dr. Santos presents results from 34 adult patients with IAAA; 29 were treated with open surgery and 5 with endovascular aneurysm repair (EVAR). After a median follow-up of 46 months (ranging from 24-112 months) renal function was equally stable in both groups. No significant differences were noted in the need for blood transfusion or intensive care, or in 30-day and long-term mortality rates, Dr. Duque-Santos said. Preoperative hydronephrosis was significantly more common in the EVAR group (3 patients, 60%) than in the open group (4 patients, 14%), but improvement in hydronephrosis occurred in 3 of 4 patients in the open group and 2 of 3 patients in the EVAR group.

 

“All patients with hydronephrosis in the open group received preoperative ureteral stenting; whereas none of the patients with hydronephrosis in the EVAR group received ureteral stents,” Dr. Duque-Santos noted.

Although the study included few patients treated with EVAR, the promising results support the need for further studies to assess long-term effectiveness; meanwhile, “open surgery remains a good and valid option for the treatment of IAAA,” Dr. Duque-Santos said.

Dr. Jianing Yue of Zhongshan Hospital Fudan University in Shanghai, will report that preoperative shock was associated with higher mortality rates in patients with truly-ruptured noninfected abdominal aortic aneurysms treated with and EVAR-optional approach (EVAR when possible) compared to those treated with an EVAR-only approach. Dr. Yue will describe data from a 7-year study including 80 adults; 27 died prior to surgery, 26 patients seen between March 2009 and April 2014were treated with EVAR if possible, and 27 seen between May 2014 and July 2016 were treated only with EVAR. In addition, the EVAR-only group had significantly shorter hospital stays than the open group (14 days vs. 34 days).

“Considering the shorter hospital stay, our results support superiority and more widespread adoption of emergent EVAR for the treatment of ruptured AAA,” Dr. Yue said.

Control of bleeding is a factor when injuries occur during accidents or surgery; Dr. Elmi Ism Olluri of Prishtina University Hospital, Kosovo, shares a case report of a 33-year-old patient who suffered extreme hypovolemic shock after blunt trauma to the right flank. The patient had complete rupture of the right kidney and a 7-cm long rupture of the infrarenal vena cava. The surgeons chose to reconstruct the infrarenal vena cava with a polytetrafluoroethylene graft. The patient also had an emergency laparotomy after a CT scan showed of a large abdominal blood clot. The patient was discharged 12 days after surgery, and 4 years later showed radiological evidence of blood flow in the IVC with a functional prosthetic graft. Salvage of a patient with a ruptured vena cava is rare, Dr. Olluri noted, but this case suggests that emergency polytetrafluoroethylene graft repair might be successful.

"Attend, attend, attend!" said co-moderator Dr. Deitzek.  "The topics are great, the presenters are young and eager and we can help foster their early careers and at the same time hear and learn about some very interesting, unusual and fascinating topics.  Be there or be square!"

Session 11
“Fascinating Venous and Aortic Topics”
Friday 7:05-9:46 a.m.
Bryant Suite, 2^nd Floor